For: | Wang YG, Xu L, Wang T, Wei J, Meng WY, Wang N, Shi M. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol 2015; 21(27): 8326-8339 [PMID: 26217084 DOI: 10.3748/wjg.v21.i27.8326] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8326.htm |
Number | Citing Articles |
1 |
Devaraj Ezhilarasan, Etienne Sokal, Mustapha Najimi. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 192 doi: 10.1016/j.hbpd.2018.04.003
|
2 |
Qiang Zhang, Lejun Lin, Weilong Li, Guowei Lu, Xinna Li. MiR-223 inhibitor suppresses proliferation and induces apoptosis of thyroid cancer cells by down-regulating aquaporin-1. Journal of Receptors and Signal Transduction 2019; 39(2): 146 doi: 10.1080/10799893.2019.1638403
|
3 |
Yunuo Yang, Jiaxuan Wu, Wenjun Zhou, Guang Ji, Yanqi Dang. Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies. MedComm 2024; 5(10) doi: 10.1002/mco2.752
|
4 |
Xin-Jie Hao, Cheng-Zhen Xu, Jin-Tai Wang, Xiao-Jie Li, Ming-Min Wang, Yi-Hai Gu, Zhi-Gang Liang. miR-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN/PI3K/AKT pathway. Journal of Receptors and Signal Transduction 2018; 38(5-6): 455 doi: 10.1080/10799893.2019.1585452
|
5 |
Athanasios Oikonomou, Titus Watrin, Luigia Valsecchi, Katerina Scharov, Angela Maria Savino, Julian Schliehe-Diecks, Michela Bardini, Grazia Fazio, Silvia Bresolin, Andrea Biondi, Arndt Borkhardt, Sanil Bhatia, Giovanni Cazzaniga, Chiara Palmi. Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening. Heliyon 2024; 10(13): e34033 doi: 10.1016/j.heliyon.2024.e34033
|
6 |
Xuan Sun, Yifei Wang, Qingyang Mai, Yixuan Fan, Qunhao Huang, Yingli Du, Hai Huang, El‐Samahy MA, Feng Wang, Guomin Zhang. Neuromedin S regulates steroidogenesis and proliferation in goat Leydig cells through modulating mitochondrial function. The FASEB Journal 2023; 37(6) doi: 10.1096/fj.202300187R
|
7 |
Haitao Sun, Xiaodong Feng. MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells. Bioscience Reports 2020; 40(5) doi: 10.1042/BSR20193867
|
8 |
Mingjuan Zhang, Su Wang, Aiwen Yi, Yongsheng Qiao. microRNA‐665 is down‐regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A. Cell Biochemistry and Function 2020; 38(4): 409 doi: 10.1002/cbf.3485
|
9 |
Haiyan Wang, Ning Ma, Wenyue Li, Zuomin Wang. MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2. Biology Open 2020; 9(3) doi: 10.1242/bio.049478
|
10 |
Xiaodan Li, Xiaolei Yao, Haiqiang Xie, Guomin Zhang, Mingtian Deng, Kaiping Deng, Xiaoxiao Gao, Yongjin Bao, Kang Li, Feng Wang. PPP2R2A affects embryonic implantation by regulating the proliferation and apoptosis of Hu sheep endometrial stromal cells. Theriogenology 2021; 176: 149 doi: 10.1016/j.theriogenology.2021.09.026
|
11 |
Adil El Taghdouini, Leo A. van Grunsven. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis. Expert Review of Gastroenterology & Hepatology 2016; 10(12): 1397 doi: 10.1080/17474124.2016.1251309
|
12 |
Jovana Markovic, Amar Deep Sharma, Asha Balakrishnan. MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury. Cells 2020; 9(8): 1767 doi: 10.3390/cells9081767
|
13 |
Wei He, Jibin Lu. MiR‐338 regulates NFATc1 expression and inhibits the proliferation and epithelial‐mesenchymal transition of human non‐small‐cell lung cancer cells. Molecular Genetics & Genomic Medicine 2020; 8(2) doi: 10.1002/mgg3.1091
|
14 |
Facheng Bai, Quanfang Huang, Jinbin Wei, Shujuan Lv, Yuxin Chen, Chunhong Liang, Ling Wei, Zhongpeng Lu, Xing Lin. Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation. International Immunopharmacology 2018; 54: 60 doi: 10.1016/j.intimp.2017.10.028
|